FindTrial
Sign In

Complementary remedy in the Management of Essential Hypertension

An Observational Study on Complementary Remedy of Prescribed Medicine in the Management of Essential Hypertension

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2019/11/022152
Enrollment
50
Registered
2019-11-26
Start date
Unknown
Completion date
Unknown
Last updated
2021-11-24

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: I10- Essential (primary) hypertension

Interventions

Intervention1: Complementary Remedy of prescribed medicine Dose and potency depending upon individual case. oral route of medication for duratoion of 6 months: Complementary Remedy of prescribed medic

Sponsors

Bakson Homoeopathic Medical College and Hospital
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: cases presenting with sign and symptom of Essential Hypertension.cases in stage 1 and 2Hypertension whose SBP is more than 140 to <180 mmhg and DBP more than 90 to <110mmhg inspite of taking or not taking conventional treatment for Essential Hypertension.

Exclusion criteria

Exclusion criteria: Age group below 30 years. Cases with secondary Hypertension. Cases with uncontrolled DM, overt manifestations of hypertensive nephropathy or retinopathy etc.

Design outcomes

Primary

MeasureTime frame
Change in symptomatology and H scale.Timepoint: Change in symptomatology and H scale.—

Secondary

MeasureTime frame
NilTimepoint: Nil—

Countries

India

Contacts

Public ContactDr Preeti Laroia

Bakson Homoeopathic Medical College And Hospital

chandani.bhms@gmail.com9540270627

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026